What is HIMS's current stock price?

As of now, HIMS is trading at $47.13, with a daily change of -2.46%.

What are HIMS stock strengths?

HIMS strengths include Investors confidence is positive, Earnings are forecast to grow, Trading below its fair value, .

What are the risks associated with HIMS stock?

HIMS Key risk is its Medium Risk Level, .

What is HIMS next earnings date?

HIMS next earnings report is scheduled for Nov 3, 2025.

What is HIMS's current stock rating?

HIMS's current stock rating is Sell.

Should I buy HIMS stock right now?

Based on the current rating of Sell, it is advisable to consider Sell as your next step with HIMS stock.

Is HIMS a Strong Buy right now?

HIMS's current stock rating is Sell, which indicates whether it is a Strong Buy, Buy, Hold, Sell, or Strong Sell.

What does a 'Strong Buy' rating mean for HIMS?

A 'Strong Buy' rating for HIMS indicates that analysts are highly confident in the stock's potential for future growth.

What does a 'Strong Sell' rating mean for HIMS?

A 'Strong Sell' rating for HIMS suggests that analysts anticipate the stock will decline significantly and may not be a good investment.

What factors influence HIMS's stock rating?

HIMS's stock rating is influenced by factors such as market trends, earnings reports, risk factors, and overall sentiment from analysts.

Hims & Hers Health I (HIMS) Stock Analysis and Insights

LOGIN

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Most Active Strong Potential Positive Momentum Earnings Calendar

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist

HIMS

Hims & Hers Health I

$47.13

-$1.19 | -2.46%

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 72.98

MKT CAP

$ 10.65B

52W Low

$ 13.47

VOL

$ 20.98M

P/E Ratio

59.21

AVG VOL

$ 33.55M

RSI

39.56

TREND

Downtrend

Chart

$47.6 (-0.99%)

$58 (-18.74%)

$36.97 (+27.48%)

$14.73 (+219.96%)

1year

6month

3month

1month

HIMS Latest Analysis +

Hims & Hers stock drops after FTC probe report.

Thu Aug 14, 2025

$47.13 | -2.46%

Momentum

Hims & Hers Health under investigation by FTC over business practices - report.

Thu Aug 14, 2025

$47.13 | -2.46%

Activity

US FTC investigating Hims & Hers over advertising and cancellation practices Bloomberg News reports.

Thu Aug 14, 2025

$47.13 | -2.46%

Activity

Hims & Hers Health stock drops after FTC probe report surfaces.

Thu Aug 14, 2025

$47.13 | -2.46%

Momentum

Hims & Hers (HIMS) Falls as Key Executives Dispose Shares.

Wed Aug 13, 2025

$48.33 | +0.77%

Momentum

Hims & Hers Remains Outside Novo Nordisks Growing Legal Storm For Now. ) has been one of 2025’.s hottest telehealth stocks nearly doubling in value year to date but a deepening clash with ) over compounded weight-loss drugs and shifting FDA rules has turned momentum into headwinds sending shares sliding 10% in the past three months.The telehealth company’.s stock has surged to almost . However over the last three months the stock has fallen around 10%. In June the stock cratered almost

Tue Aug 12, 2025

$47.96 | -4.04%

Activity

Potential

Hims & Hers Drives the Consumer-Centric Transformation in Digital Care. HIMS leverages its consumer-first telehealth model AI-driven personalization and global expansion plans to outpace industry growth.

Tue Aug 12, 2025

$47.96 | -4.04%

Activity

Momentum

Hims & Hers Health Chief Executive Officer Trades $33.38M In Company Stock. On August 11 a recent SEC filing unveiled that ) made an insider sell.United States Securities and Exchange Commission on Monday Dudum sold 660000 shares of The latest market snapshot at Tuesday morning reveals Hims &. Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals enabling them to access high-quality medical care for numerous conditions related to

Tue Aug 12, 2025

$47.96 | -4.04%

Activity

Potential

Hims & Hers: A High-Risk Bet.

Thu Aug 7, 2025

$51.05 | -0.10%

Potential

Hims & Hers Health Posts Weak Q2. Heading Into More Near-Term Challenges Analysts Say. Shares of)downbeat second-quarter revenues.The announcement came amid an exciting earnings season. Here are some key analyst takeaways.BofA Securities maintained an Underperform rating and price target of $28.Needham analyst Ryan MacDonald reiterated a Hold rating on the stock.other analyst stock ratingsHims &. Hers ...

Tue Aug 5, 2025

$55.52 | -12.36%

Rating

Explore our HIMS Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored HIMS Stock Strategies
Effective Risk Management

FIND US ON

Receive our HIMS Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

HIMS

Hims & Hers Health I

Current Price

$47.13

-$1.19 | -2.46%

52W High

$ 72.98

MKT CAP

$ 10.65B

52W Low

$ 13.47

VOL

$ 20.98M

P/E Ratio

59.21

AVG VOL

$ 33.55M

RSI

39.56

TREND

Downtrend

Create Alerts

Overview

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

HIMS Stock Rating

Login to view Hims & Hers Health I (HIMS) recommendation from the last 90 days from financial news and social media.

Chart

$47.6 (-0.99%)

$58 (-18.74%)

$36.97 (+27.48%)

$14.73 (+219.96%)

1year

6month

3month

1month

HIMS Latest Analysis

Hims & Hers stock drops after FTC probe report.

Thu Aug 14, 2025

$47.13 | -2.46%

Momentum

Hims & Hers Health under investigation by FTC over business practices - report.

Thu Aug 14, 2025

$47.13 | -2.46%

Activity

US FTC investigating Hims & Hers over advertising and cancellation practices Bloomberg News reports.

Thu Aug 14, 2025

$47.13 | -2.46%

Activity

Hims & Hers Health stock drops after FTC probe report surfaces.

Thu Aug 14, 2025

$47.13 | -2.46%

Momentum

Hims & Hers (HIMS) Falls as Key Executives Dispose Shares.

Wed Aug 13, 2025

$48.33 | +0.77%

Momentum

Hims & Hers Remains Outside Novo Nordisks Growing Legal Storm For Now. ) has been one of 2025’.s hottest telehealth stocks nearly doubling in value year to date but a deepening clash with ) over compounded weight-loss drugs and shifting FDA rules has turned momentum into headwinds sending shares sliding 10% in the past three months.The telehealth company’.s stock has surged to almost . However over the last three months the stock has fallen around 10%. In June the stock cratered almost

Tue Aug 12, 2025

$47.96 | -4.04%

Activity

Potential

Hims & Hers Drives the Consumer-Centric Transformation in Digital Care. HIMS leverages its consumer-first telehealth model AI-driven personalization and global expansion plans to outpace industry growth.

Tue Aug 12, 2025

$47.96 | -4.04%

Activity

Momentum

Hims & Hers Health Chief Executive Officer Trades $33.38M In Company Stock. On August 11 a recent SEC filing unveiled that ) made an insider sell.United States Securities and Exchange Commission on Monday Dudum sold 660000 shares of The latest market snapshot at Tuesday morning reveals Hims &. Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals enabling them to access high-quality medical care for numerous conditions related to

Tue Aug 12, 2025

$47.96 | -4.04%

Activity

Potential

Hims & Hers: A High-Risk Bet.

Thu Aug 7, 2025

$51.05 | -0.10%

Potential

Hims & Hers Health Posts Weak Q2. Heading Into More Near-Term Challenges Analysts Say. Shares of)downbeat second-quarter revenues.The announcement came amid an exciting earnings season. Here are some key analyst takeaways.BofA Securities maintained an Underperform rating and price target of $28.Needham analyst Ryan MacDonald reiterated a Hold rating on the stock.other analyst stock ratingsHims &. Hers ...

Tue Aug 5, 2025

$55.52 | -12.36%

Rating

Discover HIMS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of HIMS. We're here to help you make informed investment decisions today.

FIND US ON

Receive our HIMS Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

HIMS Stock trends

HIMS Stock performance

HIMS Stock analysis

HIMS investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score

Sign up for free and

continue analysing HIMS

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score

Sign up for free and

continue analysing HIMS

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

HIMS Stock Rating

HIMS Target Price

HIMS Risk Level

HIMS Analysts Opinion

HIMS Street Consensus

HIMS Performance Sentiment

Technical Price Levels

HIMS Financial Health

Explore our HIMS Stock insights

Receive our HIMS Daily Alerts

HIMS Stock Rating

HIMS Street Consensus

Technical Price Levels

Discover HIMS Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of HIMS. We're here to help you make informed investment decisions today.

Receive our HIMS Daily Alerts

HIMS Runner Alarm